Loading organizations...
I am unable to complete the request to write a company profile for 'Ruilian Xingshan Capital' at this time. I am encountering persistent "429 Too Many Requests" errors when attempting to fetch detailed information from prominent financial data sources such as Crunchbase, Bloomberg, and Preqin. These errors prevent me from accessing the full page content necessary to thoroughly research the company and construct a comprehensive profile that adheres to all specified guidelines, particularly the preference for evidence from fetched full-page content over snippets.
Ruilian Xingshan Capital has 1 tracked investment across 1 company. The latest tracked deal is $80.0M Series B in Porton Advanced Solutions in August 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 22, 2022 | Porton Advanced Solutions | $80.0M Series B | China Merchants Capital, Merchant Health | CS Capital, Fosun Health Capital, Gortune Investment, HM Capital, Momentum Ventures, Porton Pharma Solutions, Sdictk |
